Ad is loading...
INZY
Price
$2.80
Change
+$0.11 (+4.09%)
Updated
Nov 22, 03:18 PM (EDT)
118 days until earnings call
SPRY
Price
$13.63
Change
+$0.25 (+1.87%)
Updated
Nov 22, 03:37 PM (EDT)
118 days until earnings call
Ad is loading...

INZY vs SPRY

Header iconINZY vs SPRY Comparison
Open Charts INZY vs SPRYBanner chart's image
Inozyme Pharma
Price$2.80
Change+$0.11 (+4.09%)
Volume$100
CapitalizationN/A
ARS Pharmaceuticals
Price$13.63
Change+$0.25 (+1.87%)
Volume$400
CapitalizationN/A
INZY vs SPRY Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INZY vs. SPRY commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and SPRY is a StrongSell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (INZY: $2.69 vs. SPRY: $13.38)
Brand notoriety: INZY and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 138% vs. SPRY: 69%
Market capitalization -- INZY: $179.23M vs. SPRY: $1.3B
INZY [@Biotechnology] is valued at $179.23M. SPRY’s [@Biotechnology] market capitalization is $1.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both INZY and SPRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 3 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 7 bearish.
  • SPRY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both INZY and SPRY are a bad buy in the short-term.

Price Growth

INZY (@Biotechnology) experienced а -21.57% price change this week, while SPRY (@Biotechnology) price change was -5.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

SPRY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.3B) has a higher market cap than INZY($179M). SPRY YTD gains are higher at: 144.161 vs. INZY (-36.854). SPRY has higher annual earnings (EBITDA): -60.51M vs. INZY (-90.3M). SPRY has more cash in the bank: 205M vs. INZY (132M). SPRY has less debt than INZY: SPRY (102K) vs INZY (46.8M). SPRY has higher revenues than INZY: SPRY (2.57M) vs INZY (0).
INZYSPRYINZY / SPRY
Capitalization179M1.3B14%
EBITDA-90.3M-60.51M149%
Gain YTD-36.854144.161-26%
P/E RatioN/AN/A-
Revenue02.57M-
Total Cash132M205M64%
Total Debt46.8M102K45,882%
TECHNICAL ANALYSIS
Technical Analysis
INZYSPRY
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZDIVX27.720.31
+1.13%
Zacks Dividend Investor
CAFRX8.800.06
+0.69%
Commonwealth Africa
FDTTX25.340.17
+0.68%
Fidelity Advisor Capital Development A
TFFIX76.000.19
+0.25%
Touchstone Focused Instl
PIGRX14.020.01
+0.07%
Putnam International Value C

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-3.58%
BEAM - INZY
56%
Loosely correlated
-3.72%
FATE - INZY
49%
Loosely correlated
-6.76%
ABOS - INZY
49%
Loosely correlated
-2.53%
DNLI - INZY
49%
Loosely correlated
-0.82%
PGEN - INZY
48%
Loosely correlated
+7.91%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-1.25%
LPCN - SPRY
63%
Loosely correlated
+6.16%
INZY - SPRY
44%
Loosely correlated
-3.58%
ACLX - SPRY
41%
Loosely correlated
N/A
OABI - SPRY
39%
Loosely correlated
-1.28%
PLRX - SPRY
39%
Loosely correlated
+0.94%
More